The PI3K/AKT/mTOR pathway is frequently dysregulated in different cancer types with consequences in cell proliferation, survival, migration and invasion (Fonseca et al., 2016; Roux and Topisirovic, 2018). This evidence concerns the gene MTOR and cancer.